Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Expression, processing, and properties of int-2

C Dickson¹, F Fuller-Pace, P Kiefer

¹Laboratory of Viral Carcinogenesis, Imperial Cancer Research Fund, London, United Kingdom.

Annals of the New York Academy of Sciences

|January 1, 1991

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Physiotherapist-related barriers and enablers to the implementation of high-value physiotherapy for chronic pain: a scoping review and narrative synthesis of 37 studies.

Disability and rehabilitation·2026

Same author

Protocol for a first-in-human feasibility study of T regulatory cells (TR004) for inflammatory bowel disease using (ex vivo) Treg expansion (TRIBUTE).

BMJ open·2025

Same author

Community outbreak of invasive group A streptococcus infection in Ontario, Canada.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2019

Same author

Treatment of hepatitis C with 8 weeks of ledipasvir/sofosbuvir: Highly effective in a predominantly black male patient population.

Journal of viral hepatitis·2017

Same author

Elevating glucose and insulin secretion by carbohydrate formulation diets in late lactation to improve post-weaning fertility in primiparous sows.

Reproduction in domestic animals = Zuchthygiene·2016

Same author

Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.

Annals of the rheumatic diseases·2015